KEYNOTE-689 Archives

Adding immunotherapy before and after surgery improves outcomes in head and neck cancer patients

The phase 3 clinical trial KEYNOTE-689 shows that incorporating the monoclonal antibody pembrolizumab before and after surgery, alongside standard of…